However, a myriad of human cancers, including HCC, display anomalies in the regulation of PD-L1 expression [38], which influences tumor formation by maintaining the suppression of adaptive immune reactions and anti-tumor immunity [39–41]. The gene discussed is CD274; the disease is cancer.